IL-33 can regulate deposition of extracellular matrix (ECM) and promote the process of pulmonary fibrosis by inducing the imbalance between MMP9 and tissue inhibitor of MMP9 (TIMP-1) (17, 86). The gene discussed is IL33; the disease is pulmonary fibrosis.